about
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursThe Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cellsControl of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factorsDP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 proteinFOXM1 confers acquired cisplatin resistance in breast cancer cellsThe cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell linesHistone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistanceFoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell linesJab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1The emerging roles of forkhead box (Fox) proteins in cancerConstitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancerThe transcription factor encyclopediaRegulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone.SUMOylation inhibits FOXM1 activity and delays mitotic transition.FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.Murine gamma-herpesvirus 68 latency protein M2 binds to Vav signaling proteins and inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B cells.The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells.The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium.Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferationTumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1.Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals.FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistanceRapid temporal control of Foxp3 protein degradation by sirtuin-1.Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain.The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma.Cell-cycle regulation of human B-myb transcription.Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y).Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues.Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancersOverexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistanceNADPH oxidase-derived reactive oxygen species mediate decidualization of human endometrial stromal cells in response to cyclic AMP signaling.FoxM1 is a downstream target and marker of HER2 overexpression in breast cancerThiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.FLIM FRET technology for drug discovery: automated multiwell-plate high-content analysis, multiplexed readouts and application in situ.The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.
P50
Q21030553-C4A412F4-FB94-40D5-B078-9DE90BC7CD1FQ24294942-B4EF1944-A2EB-4CEA-9A1B-B7278577CB14Q24537205-817BE2E9-F609-4D4E-91FA-37AC922E3EDBQ24594865-2782AF6C-8BDD-46E4-A962-8F17ED64BFEFQ24642596-E0CB08C0-CD9C-4DE2-89BB-A652DF86F74FQ25254998-37058A6D-A31A-4D9F-BDFB-D4F535E59E80Q25257349-9AEF00C3-B5BC-49A8-8314-17E9D340BA72Q26864654-878165F6-7C4E-49EE-A54E-01B39BF1E138Q28207468-D4920FE1-0419-45DB-A20A-EB7D3B7B9C2FQ28214765-D4ACEDB6-0600-4191-8CF0-2CFE7B705A07Q28253741-73BB1789-C3B5-422C-824E-56D1E792DC69Q28475229-420CE2F2-D001-4C07-A720-EA8872DFC0C8Q28727892-D4EDFC24-2865-4E4E-BBC3-8A459936A6E4Q30445051-A825708B-E29E-4061-BB13-85363F752423Q30583585-39F68D1A-36FA-4F89-82D4-A0BCADB441DFQ32884377-A3FBA529-E0F3-4F1C-B637-A012475FF553Q33223011-BB05EA26-4DE9-4EBD-9494-1B49DBDA0D28Q33472952-5E3A5B0E-33A1-463F-9A01-A110273559CAQ33569562-3ABCAD60-8DFE-4D50-97BF-51946D682ADBQ33606105-31B4BEAA-6449-4CE9-9567-8C4E5CD4A27EQ33627143-DCBFF034-154F-42AA-A6F3-CED3B755BE21Q33665716-3F96550C-649D-46FE-8FB4-3F0F0B5FB23FQ33712149-51DF5D86-28A3-4093-8AAE-21D9740AC9BAQ33803307-355BED1E-487C-46DD-B0E8-B039315B2A24Q33835928-F6842049-E927-47E6-853B-7EA07EF97D24Q33869864-297455A8-9899-4026-847D-BDAA8322669BQ33886284-3483A043-2692-49B5-9E24-2DE23D88C24DQ33894047-ED34735E-2568-424A-8C1B-740D62FA17F9Q34155377-B57B26E7-9616-41AA-8C7A-E4C3D9BC555BQ34277091-D474CC0D-52B9-45D2-A4D2-84426779DF72Q34302665-09C06E22-4BA0-4462-BE1A-534BF4CE5C3AQ34322177-4BA4E4E2-D3FC-4931-8F6A-14A689AA9EEDQ34458285-DD1FBAA4-3B44-400B-9E7D-E7224F2D317EQ34499040-1C875780-7FC2-47E4-BFC7-DD020940CB53Q34550042-A5CF766D-6534-4405-B722-D2EDB6E6EB69Q34566569-0AB0D938-EAF3-4B4E-AD5E-12EFA6824758Q34725700-79972269-207E-4B83-B3EF-C0D6EDC3A0B0Q34798813-0B9607FC-4345-4207-A9F3-A4F829CB96C1Q34886345-AC5A87C9-CD00-469A-88FD-E59FFA8E8D33Q35068081-FF86A071-29F9-46BE-80D7-081BD5754E70
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric W-F Lam
@ast
Eric W-F Lam
@en
Eric W-F Lam
@es
Eric W-F Lam
@nl
Eric W-F Lam
@sl
type
label
Eric W-F Lam
@ast
Eric W-F Lam
@en
Eric W-F Lam
@es
Eric W-F Lam
@nl
Eric W-F Lam
@sl
altLabel
Eric Lam
@en
Eric W. Lam
@en
Eric W.-F. Lam
@en
prefLabel
Eric W-F Lam
@ast
Eric W-F Lam
@en
Eric W-F Lam
@es
Eric W-F Lam
@nl
Eric W-F Lam
@sl
P106
P1153
57203195755
P21
P31
P496
0000-0003-1274-3576